Skip to main content
OpenTrials
Completed

NCT Number: NCT00852865

Lactobacillus Farciminis and Hyperalgesia

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammation Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Cpc / Cic-Inserm 501

Clermont-Ferrand, 63000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy volunteers

Exclusion criteria

  • consumption of yogurts

Treatment and study plan

Lactobacillus farciminis

Drug

1 capsule per day. Each capsule containing 4*109 CFU

Placebo

Drug

1 capsule per day

Primary outcomes

  1. Measurement of the mchanical pain threshold in primary and secondary areas by using a punctate stimulus.

Secondary outcomes

  1. Measurement of cutaneous temperature of hyperalgesia areas

Sponsors and collaborators

Lead sponsor

Lallemand SAS

Industry

Registry information

Official study title

Effect of a Dialy Consumption of a Probiotic (Lactobacillus Farciminis) on Hyperalgesia in Response to Thermal Stimulation

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Feb 27, 2009
Registry last updated
May 1, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.